Omaxe Limited AI Stock Analysis
Want to see IN:OMAXE full AI Analyst Report?
Omaxe Limited (OMAXE) AI Stock Analysis
Omaxe Limited
(NSE:OMAXE)
The overall score is severely depressed by the company's precarious financial state, marked by deep losses and negative equity. This fundamental weakness is compounded by bearish technical momentum and a negative P/E ratio, leaving the stock with a high-risk profile and no clear positive catalysts.
Omaxe Limited (OMAXE) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 18.34B
- Dividend Yield
- ―
- Average Volume (3M)
- 125.93K
- Price to Earnings (P/E)
- -5.0
- Beta (1Y)
- 1.60
- Revenue Growth
- 16.72%
- EPS Growth
- 43.38%
- Country
- India
- Employees
- 468
- Sector
- General
- Sector Strength
- 55
- Industry
- Real Estate - Development
Omaxe Limited Business Overview & Revenue Model
Company Description
Omaxe Limited is an Indian entity actively involved in the property development sector. Its primary activities encompass the construction and sale of a varied range of projects, including integrated and high-tech townships, collective housing initiat...
Omaxe Limited Financial Statement Overview
Summary
Financial health is critically weak. Persistent net losses (net margin -52% in FY2026), negative shareholders' equity, and a sharp reversal to negative operating cash flow indicate severe solvency and liquidity stress, despite a large asset base.
Income Statement
10Very NegativeBalance Sheet
5Very NegativeCash Flow
8Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.48B | 13.40B | 15.61B | 16.14B | 7.73B | 6.18B |
| Gross Profit | -1.07B | -4.91B | -4.50B | -1.75B | -929.60M | 601.70M |
| EBITDA | -2.33B | -6.09B | -5.32B | -3.48B | -2.87B | -415.40M |
| Net Income | -3.69B | -6.97B | -6.86B | -4.03B | -3.48B | -1.60B |
Balance Sheet | ||||||
| Total Assets | 172.16B | 165.22B | 148.77B | 138.22B | 135.60B | 119.18B |
| Cash, Cash Equivalents and Short-Term Investments | 9.58B | 9.09B | 7.44B | 5.40B | 4.93B | 1.28B |
| Total Debt | 12.86B | 14.66B | 7.96B | 6.79B | 11.07B | 11.28B |
| Total Liabilities | 181.32B | 174.15B | 150.74B | 133.33B | 126.50B | 106.58B |
| Stockholders Equity | -9.25B | -9.02B | -2.05B | 4.80B | 8.98B | 12.45B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -4.85B | 3.28B | 9.70B | 4.49B | 7.66B |
| Operating Cash Flow | 0 | -4.55B | 3.52B | 9.87B | 4.69B | 7.83B |
| Investing Cash Flow | 0 | 165.70M | -1.55B | -640.20M | -1.42B | -221.50M |
| Financing Cash Flow | 0 | 6.28B | -863.50M | -9.24B | -2.62B | -7.40B |
Omaxe Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMAXE, the sentiment is Neutral. The current price of 100.29 is below the 20-day moving average (MA) of 101.55, below the 50-day MA of 110.15, and above the 200-day MA of 88.99, indicating a neutral trend. The MACD of -1.90 indicates Negative momentum. The RSI at 47.27 is Neutral, neither overbought nor oversold. The STOCH value of 65.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:OMAXE.
Omaxe Limited Peers Comparison
Overall Rating
IN:AJMERA62Neutral
IN:SHRIRAMPPS62Neutral
IN:ARVSMART55Neutral
IN:KOLTEPATIL50Neutral
IN:OMAXE41.6Neutral
IN:ARIHANTSUP40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 62Neutral | INR 26.31B | 15.35 | ― | 0.75% | 51.71% | 30.62% | |
| 62Neutral | INR 12.05B | 13.18 | ― | ― | 33.44% | 13.37% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 28.49B | 14.94 | ― | 0.36% | 5.31% | 54.09% | |
| 50Neutral | INR 40.53B | 29.09 | ― | ― | 7.76% | 27.78% | |
| 42Neutral | INR 18.34B | -4.96 | ― | ― | 16.72% | 43.38% | |
| 40Underperform | INR 9.17B | 31.59 | ― | 0.12% | 4.66% | -51.13% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:OMAXE | Omaxe Limited | 100.29 | 25.91 | 34.83% | |
| IN:AJMERA | Ajmera Realty & Infra India Ltd | 133.70 | -60.63 | -31.20% | |
| IN:ARIHANTSUP | Arihant Superstructures Limited | 212.00 | -165.06 | -43.78% | |
| IN:ARVSMART | Arvind SmartSpaces Ltd. | 620.45 | 22.02 | 3.68% | |
| IN:KOLTEPATIL | Kolte-Patil Developers Limited | 457.00 | 48.60 | 11.90% | |
| IN:SHRIRAMPPS | Shriram Properties Ltd. | 70.61 | -20.53 | -22.53% |
Omaxe Limited Corporate Events
Omaxe Forms Wholly Owned Subsidiary for Lucknow Bus Terminal PPP Project
Omaxe Limited has incorporated a new wholly owned subsidiary, Omaxe Lucknow Bus Terminal Private Limited, in India to undertake real estate activities focused on projects under the public-private partnership model. The subsidiary falls within the rea...
Omaxe Board to Review September Quarter Results; Trading Window Stays Shut
Omaxe Limited has notified the stock exchanges that its Board of Directors will meet on October 27, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. In li...
Omaxe Shareholders Clear All Resolutions at Digitally Conducted 37th AGM
Omaxe Limited has reported the voting results of its 37th Annual General Meeting, held on September 25, 2026 via video conferencing and other audio-visual means, in line with regulatory and pandemic-era governance guidelines. All resolutions proposed...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
